Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects

References

• MozaffarianDWilsonPWKannelWBBeyond established and novel risk factors: lifestyle risk factors for cardiovascular diseaseCirculation2008117233031303818541753
   PubMed Web of Science ®Google Scholar
• RossRAtherosclerosis: an inflammatory diseaseN Engl J Med199934021151269887164
   PubMed Web of Science ®Google Scholar
• VanhouttePMShimokawaHTangEHFeletouMEndothelial dysfunction and vascular diseaseActa Physiol20091962193222
   PubMed Web of Science ®Google Scholar
• LibbyPInflammation in atherosclerosisNature2002420691786887412490960
   PubMed Web of Science ®Google Scholar
• PerticoneFCeravoloRPujiaAPrognostic significance of endothelial dysfunction in hypertensive patientsCirculation2001104219119611447085
   PubMed Web of Science ®Google Scholar
• HalcoxJPSchenkeWHZalosGPrognostic value of coronary vascular endothelial dysfunctionCirculation2002106665365812163423
   PubMed Web of Science ®Google Scholar
• DavignonJGanzPRole of endothelial dysfunction in atherosclerosisCirculation200410923 Suppl 1III273215198963
   PubMed Web of Science ®Google Scholar
• KatzSDHryniewiczKHriljacIVascular endothelial dysfunction and mortality risk in patients with chronic heart failureCirculation2005111331031415655134
   PubMed Web of Science ®Google Scholar
• DeanfieldJEHalcoxJPRabelinkTJEndothelial function and dysfunction: testing and clinical relevanceCirculation2007115101285129517353456
   PubMed Web of Science ®Google Scholar
• CorrettiMCAndersonTJBenjaminEJInternational brachial artery reactivity task forceGuidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task forceJ Am Coll Cardiol200239225726511788217
   PubMed Web of Science ®Google Scholar
• BotsMLWesterinkJRabelinkTJde KoningEJAssessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD responseEur Heart J200526436336815618057
   PubMed Web of Science ®Google Scholar
• WidlanskyMEGokceNKeaneyJFJrVitaJAThe clinical implications of endothelial dysfunctionJ Am Coll Cardiol20034271149116014522472
   PubMed Web of Science ®Google Scholar
• CaiHHarrisonDGEndothelial dysfunction in cardiovascular diseases: the role of oxidant stressCirc Res2000871084084411073878
   PubMed Web of Science ®Google Scholar
• HigashiYNomaKYoshizumiMKiharaYEndothelial function and oxidative stress in cardiovascular diseasesCirc J200973341141819194043
   PubMed Web of Science ®Google Scholar
• RidkerPMBrownNJVaughanDEHarrisonDGMehtaJLEstablished and emerging plasma biomarkers in the prediction of first atherothrombotic eventsCirculation200410925 Suppl 1IV61915226246
   PubMed Web of Science ®Google Scholar
• DohiYTakaseHSatoKUedaRAssociation among C-reactive protein, oxidative stress, and traditional risk factors in healthy Japanese subjectsInt J Cardiol20071151636616759717
   PubMed Web of Science ®Google Scholar
• BlakeGJRidkerPMC-reactive protein and other inflammatory risk markers in acute coronary syndromesJ Am Coll Cardiol2003414 Suppl S37S42S12644339
   PubMed Web of Science ®Google Scholar
• WalterMFJacobRFJeffersBPREVENT studySerum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT studyJ Am Coll Cardiol200444101996200215542282
   PubMed Web of Science ®Google Scholar
• KiechlSWilleitJMayrMOxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck studyArterioscler Thromb Vasc Biol20072781788179517541022
   PubMed Web of Science ®Google Scholar
• CesaroneMRBelcaroGCarratelliMA simple test to monitor oxidative stressInt Angiol199918212713010424368
   PubMed Web of Science ®Google Scholar
• KamezakiFYamashitaKKubaraTDerivatives of reactive oxygen metabolites correlates with high-sensitivity C-reactive proteinJ Atheroscler Thromb200815420621218776704
   PubMed Web of Science ®Google Scholar
• HiroseHKawabeHKomiyaNSaitoIRelations between serum reactive oxygen metabolites (ROMs) and various inflammatory and metabolic parameters in a Japanese populationJ Atheroscler Thromb2009162778219403985
   PubMed Web of Science ®Google Scholar
• GuoXKoJKMeiQBChoCHAggravating effect of cigarette smoke exposure on experimental colitis is associated with leukotriene B(4) and reactive oxygen metabolitesDigestion200163318018711351145
   PubMed Web of Science ®Google Scholar
• TeramotoTSasakiJUeshimaHJapan Atherosclerosis Society (JAS) Committee for Epidemiology and Clinical Management of AtherosclerosisDiagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for JapaneseJ Atheroscler Thromb200714415515817827859
   PubMed Web of Science ®Google Scholar
• OgiharaTKikuchiKMatsuokaHJapanese Society of Hypertension CommitteeThe Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009)Hypertens Res2009321310719300436
   PubMed Web of Science ®Google Scholar
• SugiuraTKondoTKureishi-BandoYNifedipine improves endothelial function: role of endothelial progenitor cellsHypertension200852349149818645050
   PubMed Web of Science ®Google Scholar
• HillJMZalosGHalcoxJPCirculating endothelial progenitor cells, vascular function, and cardiovascular riskN Engl J Med2003348759360012584367
   PubMed Web of Science ®Google Scholar
• HeissCKeymelSNieslerUZiemannJKelmMKalkaCImpaired progenitor cell activity in age-related endothelial dysfunctionJ Am Coll Cardiol20054591441144815862416
   PubMed Web of Science ®Google Scholar
• BrinkleyTENicklasBJKanayaAMPlasma oxidized low-density lipoprotein levels and arterial stiffness in older adults: the health, aging, and body composition studyHypertension200953584685219332658
   PubMed Web of Science ®Google Scholar
• TanagaKBujoHInoueMIncreased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particlesArterioscler Thromb Vasc Biol200222466266611950707
   PubMed Web of Science ®Google Scholar
• MarchesiEMartignoniASalviniMCarotid intima-media thickening and in vivo LDL oxidation in patients with essential hypertensionJ Hum Hypertens19961095775828953201
   PubMed Web of Science ®Google Scholar
• MiyazakiTShimadaKSatoOCirculating malondialdehyde-modified LDL and atherogenic lipoprotein profiles measured by nuclear magnetic resonance spectroscopy in patients with coronary artery diseaseAtherosclerosis2005179113914515721020
   PubMed Web of Science ®Google Scholar
• DoustJAPietrzakEDobsonAGlasziouPHow well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: Systematic reviewBMJ2005330749262563415774989
   PubMed Web of Science ®Google Scholar
• TakaseHToriyamaTSugiuraTBrain natriuretic peptide detects cardiac abnormalities in mass screeningEur J Clin Invest20073742562
   Web of Science ®Google Scholar